MDLifespan schedules webinar on advanced serial plasma exchange

By AI, Created 10:00 AM UTC, May 20, 2026, /AGP/ – Chicago-based MDLifespan will host a virtual clinician webinar on May 29 on advanced serial therapeutic plasma exchange, a protocol-driven approach aimed at removing circulating toxins and inflammatory substances. The session is designed for physicians treating complex, chronic inflammatory cases and will cover evidence, patient selection and practice integration.

Why it matters: - Physicians are seeing more patients with persistent inflammatory burden, environmental toxin exposure and multi-system symptoms that standard care may not fully address. - MDLifespan is positioning advanced serial therapeutic plasma exchange as a mechanism-based option for cases involving circulating toxins, immune complexes and inflammatory proteins. - The webinar targets specialties that commonly manage complex chronic conditions, including cardiology, oncology, integrative medicine and longevity medicine.

What happened: - MDLifespan, a Chicago-based physician-led startup, is hosting a virtual clinical webinar on Friday, May 29, 2026, at 11:00 a.m. CST. - The event is titled “Physician’s Guide to Advanced Serial Therapeutic Plasma Exchange: The Science, the Evidence, and the Opportunity for Your Patients.” - Registration is available through the webinar link. - Dr. Paul Savage, founder and chief medical officer of MDLifespan, will present the session.

The details: - Advanced Serial Therapeutic Plasma Exchange removes plasma containing targeted substances and replaces it with clean fluid. - Traditional therapeutic plasma exchange is already established for acute and autoimmune indications. - MDLifespan says the advanced serial approach uses structured, protocol-driven treatment strategies. - The model includes serial treatments, nutritional and lifestyle considerations, and biomarker tracking over time. - The webinar will explain the mechanism of action, the rationale for serial protocols and the differences between traditional and advanced serial approaches. - Physicians will also hear about observational biomarker trends, clinical frameworks, patient selection, safety parameters and how the therapy fits into existing practice models. - The session will include select clinical case examples tied to toxin burden, inflammation and complex patient presentations. - Dr. Savage is a CME lecturer on therapeutic plasma exchange and the author of Avoiding Toxins. - MDLifespan says the company operates as a referral-based partner that lets physicians expand options for appropriate patients while keeping continuity of care.

Between the lines: - The event reflects growing physician interest in interventions aimed at circulating biological and environmental factors rather than only downstream symptoms. - MDLifespan is using the webinar to frame advanced serial TPE as part of a broader shift toward protocol-based, data-informed care. - The referral model suggests the company wants to fit into, rather than replace, the referring physician’s long-term role in patient management. - The focus on biomarker tracking and clinical frameworks signals an effort to present the therapy as structured and measurable, not purely experimental.

What’s next: - Physicians interested in the therapy can register for the May 29 webinar. - MDLifespan is expected to continue expanding its national footprint and referral network. - The company says the session will help clinicians evaluate whether advanced serial TPE may fit into care for patients with chronic inflammation and toxin burden.

The bottom line: - MDLifespan is betting that more physicians want practical guidance on plasma exchange as a tool for complex chronic cases, and the Chicago webinar is meant to make that case.